MyFinsight
Home
Blog
About
Cash and cash
equivalents
$132,969K
Short-term investments
$117,083K
Inventory
$45,409K
Accounts receivable
$20,344K
Prepaid expenses and
other current assets
$15,577K
Total current assets
$331,382K
Operating lease
right-of-use assets
$35,798K
Property and equipment,
net
$13,358K
Restricted cash
$6,254K
Other assets -
noncurrent
$2,578K
Capitalized software, net
$1,605K
Total assets
$390,975K
Total liabilities,
convertible preferred stock...
$390,975K
Total stockholders'
equity (deficit)
$312,857K
Total liabilities
$78,118K
Accumulated deficit
-$203,299K
Accumulated other
comprehensive loss
-$139K
Additional paid-in capital
$516,288K
Long-term operating lease
liabilities
$39,182K
Total current
liabilities
$27,960K
Term debt
$9,947K
Other noncurrent
liabilities
$1,029K
Common stock
$7K
Accounts payable
$13,790K
Accrued and other
current liabilities
$11,893K
Short-term operating lease
liabilities
$2,277K
Back
Back
Balance Sheet
Alamar Biosciences, Inc. (ALMR)
Alamar Biosciences, Inc. (ALMR)
source: myfinsight.com